-
901
-
902por Arnaud, Noëlla, Dabo, Stéphanie, Maillard, Patrick, Budkowska, Agata, Kalliampakou, Katerina I., Mavromara, Penelope, Garcin, Dominique, Hugon, Jacques, Gatignol, Anne, Akazawa, Daisuke, Wakita, Takaji, Meurs, Eliane F.“…Hepatitis C virus is a poor inducer of interferon (IFN), although its structured viral RNA can bind the RNA helicase RIG-I, and activate the IFN-induction pathway. …”
Publicado 2010
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
903“…The p7 protein of hepatitis C virus (HCV) plays an important role in the viral lifecycle. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
904por Harris, Helen J., Davis, Christopher, Mullins, Jonathan G. L., Hu, Ke, Goodall, Margaret, Farquhar, Michelle J., Mee, Christopher J., McCaffrey, Kitty, Young, Stephen, Drummer, Heidi, Balfe, Peter, McKeating, Jane A.“…Viruses initiate infection by attaching to molecules or receptors at the cell surface. Hepatitis C virus (HCV) enters cells via a multistep process involving tetraspanin CD81, scavenger receptor class B member I, and the tight junction proteins Claudin-1 and Occludin. …”
Publicado 2010
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
905por Ray, Ranjit, Meyer, Keith, Banerjee, Arup, Basu, Arnab, Coates, Stephen, Abrignani, Sergio, Houghton, Michael, Frey, Sharon E., Belshe, Robert B.“…Hepatitis C virus (HCV) envelope glycoproteins E1 and E2 were used with MF59 adjuvant as a candidate vaccine for a phase 1 safety and immunogenicity trial. …”
Publicado 2010
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
906“…Six major Hepatitis C virus (HCV) genotypes and hundreds of subtypes have been identified globally. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
907por Baldick, Carl J., Wichroski, Michael J., Pendri, Annapurna, Walsh, Ann W., Fang, Jie, Mazzucco, Charles E., Pokornowski, Kevin A., Rose, Ronald E., Eggers, Betsy J., Hsu, Mayla, Zhai, Weixu, Zhai, Guangzhi, Gerritz, Samuel W., Poss, Michael A., Meanwell, Nicholas A., Cockett, Mark I., Tenney, Daniel J.“…Small molecule inhibitors of hepatitis C virus (HCV) are being developed to complement or replace treatments with pegylated interferons and ribavirin, which have poor response rates and significant side effects. …”
Publicado 2010
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
908por Freitas, Nara R, Teles, Sheila A, Matos, Marcos A, Lopes, Carmen LR, Reis, Nádia RS, Espírito-Santo, Márcia P, Lampe, Elisabeth, Martins, Regina MB“…Hepatitis C virus (HCV) infection is a global public health problem. …”
Publicado 2010
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
909“…A significant proportion of patients with chronic hepatitis C virus (HCV) infection develop liver cirrhosis and complications of end-stage liver disease over two to three decades and require liver transplantation, however, reinfection is common and leads to further adverse events under immunosuppression. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
910por Weclawiak, Hugo, Kamar, Nassim, Ould-Mohamed, Abdellatif, Cardeau-Desangles, Isabelle, Izopet, Jacques, Rostaing, Lionel“…Hepatitis C virus (HCV) infection is a blood-borne infection and its prevalence used to be elevated in hemodialysis (HD) patients. …”
Publicado 2010
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
911por Ali, Amjad, Ahmad, Habib, Ali, Ijaz, Khan, Sheema, Zaidi, Gulshan, Idrees, Muhammad“…Prevalence of active hepatitis C virus (HCV) infection in apparently healthy inhabitants of District Mansehra, Pakistan was surveyed during September, 2009 to May, 2010. …”
Publicado 2010
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
912“…Chronic hepatitis C is a major cause of chronic liver disease globally, and the natural history of progression may lead to cirrhosis with liver failure, hepatocellular carcinoma, and premature liver-related death. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
913“…BACKGROUND: Hepatitis C is a major health problem causes liver cirrhosis, hepatocellular carcinoma and death. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
914“…The mathematical model for the dynamics of the hepatitis C proposed in Avendaño et al. (2002), with four populations (healthy and unhealthy hepatocytes, the viral load of the hepatitis C virus, and T killer cells), is revised. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
915
-
916por Yoshida, Takeshi, Kondoh, Masuo, Ojima, Manabu, Mizuguchi, Hiroyuki, Yamagishi, Yoshiaki, Sakamoto, Naoya, Yagi, Kiyohito“…The efficient delivery of the hepatitis C virus (HCV) RNA subgenomic replicon into cells is useful for basic and pharmaceutical studies. …”
Publicado 2011
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
917por Gray, Rebecca R, Parker, Joe, Lemey, Philippe, Salemi, Marco, Katzourakis, Aris, Pybus, Oliver G“…BACKGROUND: Hepatitis C virus (HCV) is a rapidly-evolving RNA virus that establishes chronic infections in humans. …”
Publicado 2011
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
918“…Hepatitis C virus (HCV) is the main cause of severe liver disease, including hepatocellular carcinoma, cirrhosis and end stage liver disease. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
919“…For persons living with HIV, hepatitis C is a major public health problem that must be controlled and could be eliminated. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
920por Ashfaq, Usman A, Yousaf, Muhammad Z, Aslam, Maida, Ejaz, Rahat, Jahan, Shah, Ullah, Obaid“…Hepatitis C virus is a major cause of chronic liver diseases which can lead to permanent liver damage, hepatocellular carcinoma and death. …”
Publicado 2011
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto